#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frontotemporal dementia Ovarian cancer Pulmonary sarcoidosis Familial amyotrophic lateral sclerosis Primitive neuroectodermal tumour Brain abscess Diffuse large B-cell lymphoma Alexander disease Anaplastic thyroid cancer Dementia with Lewy bodies Oesophageal squamous cell carcinoma stage III Amyotrophic lateral sclerosis Cholangitis sclerosing Hypochromic anaemia Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    VEXAS syndrome Andersen-Tawil syndrome – Basic Information Prader-Willi syndrome – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Systemic mastocytosis – Treatment Inclusion body myositis – Diagnostics Mantle cell lymphoma stage III – Basic Information Mantle cell lymphoma – Diagnostics Lennox-Gastaut syndrome – Basic Information Glycogen storage disease type I – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olive Oil, Refined Levonorgestrel Protein C Carbamazepine (Ph. Eur.) Elasomeran Magnesium Citrate Deucrictibant Povidone, Iodinated Estriol Micafungin Iopamidol Magnesium Stearate GSKVX000000034798 Sodium Ascorbate Erenumab Regadenoson Pemetrexed Diacid Monohydrate Clobetasol Propionate NORGESTIMATE Odronextamab More therapies…

    Learn about Your Condition

    Ependymoma Colorectal adenoma Infertility Dry mouth Bladder cancer recurrent Renal cell carcinoma Allergic respiratory disease Benign prostatic hyperplasia Multiple sclerosis Pelizaeus-Merzbacher disease Rectal neoplasm Osteogenesis imperfecta Rhabdomyosarcoma recurrent Hyperhidrosis Pseudoxanthoma elasticum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of MK-1084, cetuximab and mFOLFOX6 combination compared to mFOLFOX6 with or without bevacizumab for patients with KRAS G12C-mutant advanced colorectal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • K-ras gene mutation
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Mk-1084
    • Bevacizumab
    • Calcium Folinate
    Finland France Germany Hungary Italy The Netherlands +3

  • Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Gemcitabine Hydrochloride
    • Paclitaxel
    Belgium Czechia Denmark Finland France Germany +7

  • Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    France Germany Greece Italy Poland Portugal +1

  • Study on Atorvastatin’s Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    • Triple negative breast cancer
    Investigated Drugs:
    • Atorvastatin
    Italy

  • Study on the Safety and Effectiveness of Telisotuzumab Adizutecan and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    • Bevacizumab
    • Fluorouracil
    Austria Czechia France Greece Italy Spain

  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • SIGVOTATUG VEDOTIN
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Docetaxel
    • Irinotecan Hydrochloride
    Belgium Denmark France Germany Italy The Netherlands +5

  • Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Bevacizumab
    • Cetuximab
    Italy Spain

  • Study on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Bevacizumab
    • Calcium Folinate
    France Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Abemaciclib
    • Anastrozole
    Austria Belgium France Germany Italy The Netherlands +3
Previous Page
1 … 5 6 7 8 9 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!